Exclusive

Publication

Byline

FOOD AND DRUG ADMINISTRATION ISSUES NOTICE: AGENCY INFORMATION COLLECTION ACTIVITIES; PROPOSED COLLECTION; COMMENT REQUEST; REQUIRED WARNINGS FOR CIGARETTE PACKAGES AND ADVERTISEMENTS

WASHINGTON, Dec. 19 -- Food and Drug Administration has issued a notice called: Agency Information Collection Activities; Proposed Collection; Comment Request; Required Warnings for Cigarette Packages... Read More


FOOD AND DRUG ADMINISTRATION ISSUES NOTICE: NOTICE OF APPROVAL OF PRODUCT UNDER VOUCHER: RARE PEDIATRIC DISEASE PRIORITY REVIEW VOUCHER; KEYTRUDA QLEX (PEMBROLIZUMAB AND BERAHYALURONIDASE ALFA-PMPH)

WASHINGTON, Dec. 19 -- Food and Drug Administration has issued a notice called: Notice of Approval of Product Under Voucher: Rare Pediatric Disease Priority Review Voucher; KEYTRUDA QLEX (pembrolizuma... Read More


FOOD AND DRUG ADMINISTRATION ISSUES NOTICE: PROCESSES AND PRACTICES APPLICABLE TO BIORESEARCH MONITORING INSPECTIONS; GUIDANCE FOR INDUSTRY; AVAILABILITY

WASHINGTON, Dec. 19 -- Food and Drug Administration has issued a notice called: Processes and Practices Applicable to Bioresearch Monitoring Inspections; Guidance for Industry; Availability. The noti... Read More


FOOD AND DRUG ADMINISTRATION ISSUES NOTICE: DETERMINATION THAT DEXCHLORPHENIRAMINE MALEATE (DEXCHLORPHENIRAMINE MALEATE, ORAL SYRUP, 2 MILLIGRAMS/5 MILLILITERS) WAS NOT WITHDRAWN FROM SALE FOR REASONS OF SAFETY OR EFFECTIVENESS

WASHINGTON, Dec. 19 -- Food and Drug Administration has issued a notice called: Determination That DEXCHLORPHENIRAMINE MALEATE (Dexchlorpheniramine Maleate, Oral Syrup, 2 Milligrams/5 Milliliters) Was... Read More


FOOD AND DRUG ADMINISTRATION ISSUES NOTICE: ISSUANCE OF PRIORITY REVIEW VOUCHER; RARE PEDIATRIC DISEASE PRODUCT; FORZINITY (ELAMIPRETIDE)

WASHINGTON, Dec. 19 -- Food and Drug Administration has issued a notice called: Issuance of Priority Review Voucher; Rare Pediatric Disease Product; FORZINITY (Elamipretide). The notice was published... Read More


FOOD AND DRUG ADMINISTRATION ISSUES NOTICE: AGENCY INFORMATION COLLECTION ACTIVITIES; ANNOUNCEMENT OF OFFICE OF MANAGEMENT AND BUDGET APPROVALS

WASHINGTON, Dec. 19 -- Food and Drug Administration has issued a notice called: Agency Information Collection Activities; Announcement of Office of Management and Budget Approvals. The notice was pub... Read More


FOOD AND DRUG ADMINISTRATION ISSUES NOTICE: DETERMINATION THAT EFFEXOR XR (VENLAFAXINE HYDROCHLORIDE) EXTENDED-RELEASE CAPSULE, 100 MILLIGRAMS, WAS NOT WITHDRAWN FROM SALE FOR REASONS OF SAFETY OR EFFECTIVENESS

WASHINGTON, Dec. 19 -- Food and Drug Administration has issued a notice called: Determination That EFFEXOR XR (Venlafaxine Hydrochloride) Extended-Release Capsule, 100 Milligrams, Was Not Withdrawn Fr... Read More


ADMINISTRATION FOR CHILDREN AND FAMILIES ISSUES NOTICE: STATEMENT OF ORGANIZATION, FUNCTIONS, AND DELEGATIONS OF AUTHORITY

WASHINGTON, Dec. 19 -- Administration for Children and Families has issued a notice called: Statement of Organization, Functions, and Delegations of Authority. The notice was published in the Federal... Read More


CENTERS FOR MEDICARE & MEDICAID SERVICES ISSUES NOTICE: ANNOUNCEMENT OF THE APPROVAL OF COLA AS AN ACCREDITATION ORGANIZATION FOR THE SPECIALTIES OF CLINICAL CYTOGENETICS AND RADIOBIOASSAY UNDER THE CLINICAL LABORATORY IMPROVEMENT AMENDMENTS OF 1988

WASHINGTON, Dec. 19 -- Centers for Medicare & Medicaid Services has issued a notice called: Announcement of the Approval of COLA as an Accreditation Organization for the Specialties of Clinical Cytoge... Read More


CENTERS FOR DISEASE CONTROL AND PREVENTION ISSUES NOTICE: CAUTI EVENTS AMONG PATIENTS WITH SPINAL CORD INJURY-ASSOCIATED NEUROGENIC BLADDER (SCI-NB); REQUEST FOR INFORMATION: REOPENING OF COMMENT PERIOD

WASHINGTON, Dec. 19 -- Centers for Disease Control and Prevention has issued a notice called: CAUTI Events Among Patients With Spinal Cord Injury-Associated Neurogenic Bladder (SCI-NB); Request for In... Read More